TAK · NYSE · STOCK
Takeda Pharmaceutical Company Limited
$17.49
52W $12.99 – $18.90
67/100
$55.62B
48.9
0.09
Is TAK Bullish or Bearish?
Mixed.
Innellis AI committee rates Takeda Pharmaceutical Company Limited (TAK) Insufficient Data with a composite score of 67/100
, based on 3 analysts with 67% agreement.
Last updated August 11, 2026.
What Would Change This View
No threshold can be published for TAK. The committee has not produced a scored recommendation, so there is no line for it to cross. Innellis does not infer one.
Executive Summary
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
67/100
Agreement
67%
Analysts
3
Conviction
Low Data
Sector Rank
Top 10%
of 192 Healthcare peers
Technical Analyst
bullish
63
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− Price structure (LH_LL) contradicts the uptrend -- mixed signals
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
61.6
Neutral
MACD Histogram
0.004
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$14.86
Resistance
$18.82
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$17.24
Above
EMA 21
$17.04
Above
EMA 50
$16.78
Above
EMA 200
$16.36
Above
Fundamental Analysis
Valuation
57
Profitability
36
Financial Health
60
Cash Flow
70
Valuation
P/E Ratio
48.9×
P/B Ratio
1.15×
PEG Ratio
1.59
Dividend Yield
3.58%
52W High
$18.90
52W Low
$12.99
Quality & Growth
ROE
260.4%
ROA
131.0%
Gross Margin
6214.7%
Operating Margin
1052.0%
Revenue Growth YoY
—
Debt / Equity
0.65
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 48.9 (rich relative to a 15-40x range); Price-to-book of 1.2x; PEG ratio of 1.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 2.6%; Return on assets of 1.3%; Net margin of 3.9%; Gross margin of 62.1%; Current ratio of 1.14 (tight short-term liquidity); Debt-to-equity of 0.65; Free cash flow per share is positive (224.07); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full TAK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →